Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA327990

Local Sample ID:	D 46-01-9572
Subject ID:	SU003140
Subject Type:	Human
Subject Species:	Homo sapiens
Taxonomy ID:	9606

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR003149
Treatment Summary:	No treatment. The participants' ages ranged from 18 to 75 years. We categorized our study population into three groups based on participants' BMI values, glycemic parameters, and the presence of at least two components of Metabolic Syndrome (MetS), along with central obesity, as per the definition specified by the International Diabetes Federation (IDF). Recruiters were divided into three groups: 1. Group 1 (Normal weight individuals as control): Normoglycemic (with HbA1c<5.7% or FPG <100 mg/dL) and lean with 19.5< BMI kg\m² < 25. 2. Group 2 (Overweight individuals): Non-diabetic subjects as well as overweight of BMI ≥25 kg/m2 having three or more of the MetS components as delineated by the International Diabetes Federation (IDF). 3. Group 3 (Obese individuals): Non-diabetic subjects as well as obese of BMI ≥ 30 kg/m2 having three or more of the MetS components as delineated by the International Diabetes Federation (IDF).

Treatment ID:

TR003149

Treatment Summary:

No treatment. The participants' ages ranged from 18 to 75 years. We categorized our study population into three groups based on participants' BMI values, glycemic parameters, and the presence of at least two components of Metabolic Syndrome (MetS), along with central obesity, as per the definition specified by the International Diabetes Federation (IDF). Recruiters were divided into three groups: 1. Group 1 (Normal weight individuals as control): Normoglycemic (with HbA1c<5.7% or FPG <100 mg/dL) and lean with 19.5< BMI kg\m² < 25. 2. Group 2 (Overweight individuals): Non-diabetic subjects as well as overweight of BMI ≥25 kg/m2 having three or more of the MetS components as delineated by the International Diabetes Federation (IDF). 3. Group 3 (Obese individuals): Non-diabetic subjects as well as obese of BMI ≥ 30 kg/m2 having three or more of the MetS components as delineated by the International Diabetes Federation (IDF).